ascopubs.org

Relationship Between ERCC1 Polymorphisms, Disease Progression, and Survival in the Gynecologic Oncology Group Phase III Trial of Intraperitoneal Versus Intravenous Cisplatin ...

Single nucleotide polymorphism analysis was carried out by direct pyrosequencing at two sites (codon 118 and C8092A) in ERCC1 in leukocyte DNA from women who participated in the Gynecologic Oncology ...

Tackling chemotherapy resistance in throat cancer—a potential new pathway

A University of Sheffield researcher has uncovered new evidence that could help improve treatment options for patients with ...
ascopubs.org

Excision repair cross-complementing 1 (ERCC1) and survival in advanced bladder cancer: Confirmatory results using immunohistochemistry

Correlation of multidrug-resistance gene (MDR1) expression levels and outcome to adjuvant cisplatin/MTX based chemotherapy in patients enrolled in the AUO-AB 05/95 phase III trial No significant ...
News Medical

Biochemists reveal how to prevent cancer cells from becoming resistant to chemotherapy

Biochemists from RUDN University described how to prevent cancer cells from becoming resistant to chemotherapy drugs. Having determined the resistance mechanism, biochemists selected a drug that can ...
EurekAlert!

Team from Korea University medicine explores ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Cisplatin is a potent chemotherapeutic agent used to treat various cancers, including cervical cancer. But the continued use of cisplatin can lead to the development of cisplatin resistance and other ...